Related Experiment Video
Updated: Jul 4, 2025

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
Platelets modulate cardiac remodeling via the collagen receptor GPVI after acute myocardial infarction
Friedrich Reusswig1, Matthias Dille1, E Krüger1
1Department of Vascular- and Endovascular Surgery, University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.
Insights
Glycoprotein VI (GPVI) deficiency in mice improves cardiac remodeling after myocardial infarction by reducing platelet activation and altering scar collagen. This suggests GPVI is a therapeutic target for improving heart healing post-ischemia reperfusion injury.
Area of Science:
- Cardiovascular Biology
- Platelet Physiology
- Immunology
Background:
- Platelets are crucial in cardiovascular diseases, with enhanced activation post-myocardial infarction.
- Platelet glycoprotein VI (GPVI) is a key collagen receptor involved in platelet activation and thrombus stability.
- Previous studies suggested GPVI's role in inflammation and infarct size reduction, but its precise function in cardiac remodeling remained unclear.
Purpose of the Study:
- To investigate the role of GPVI in cardiac remodeling and function following experimental acute myocardial infarction (AMI).
- To determine if GPVI deficiency impacts inflammation, pro-coagulant activity, and scar formation post-AMI.
Main Methods:
- Utilized GPVI-deficient mice in a closed-chest model of experimental AMI.
- Analyzed inflammatory responses, platelet activation via GPVI and PAR4 receptor stimulation, and pro-coagulant activity.
- Assessed plasma levels of TGF-β and gene expression related to cardiac remodeling (Col1a1, Col3a1, periostin, Cthrc1) at 7 days post-AMI.
- Evaluated scar collagen quality and cardiac function at 21 days post-AMI.
Main Results:
- GPVI deficiency did not significantly affect the inflammatory response in experimental AMI.
- Reduced platelet activation in GPVI-deficient mice led to decreased pro-coagulant activity.
- GPVI deficiency resulted in reduced plasma TGF-β levels and altered expression of cardiac remodeling genes.
- Scar collagen quality improved, characterized by tighter, less fine collagen, leading to enhanced cardiac function in GPVI-deficient mice.
Conclusions:
- GPVI is identified as a significant regulator of platelet-induced cardiac remodeling post-AMI.
- Targeting GPVI may offer a therapeutic strategy to mitigate ischemia reperfusion injury and promote cardiac healing.
Introduction:
Platelets play an important role in cardiovascular diseases. After acute myocardial infarction, platelets display enhanced activation and migrate into the infarct zone. Furthermore, platelets trigger acute inflammation and cardiac remodeling leading to alterations in scar formation and cardiac function as observed in thrombocytopenic mice. GPVI is the major collagen receptor in platelets and important for platelet activation and thrombus formation and stability. Antibody induced deletion of GPVI at the platelet surface or treatment of mice with recombinant GPVI-Fc results in reduced inflammation and decreased infarct size in a mouse model of AMI. However, the role of GPVI has not been fully clarified to date.
Methods/Results:
In this study, we found that GPVI is not involved in the inflammatory response in experimental AMI using GPVI deficient mice that were analyzed in a closed-chest model. However, reduced platelet activation in response to GPVI and PAR4 receptor stimulation resulted in reduced pro-coagulant activity leading to improved cardiac remodeling. In detail, GPVI deficiency in mice led to reduced TGF-β plasma levels and decreased expression of genes involved in cardiac remodeling such as Col1a1, Col3a1, periostin and Cthrc1 7 days post AMI. Consequently, collagen quality of the scar shifted to more tight and less fine collagen leading to improved scar formation and cardiac function in GPVI deficient mice at 21d post AMI.
Conclusion:
Taken together, this study identifies GPVI as a major regulator of platelet-induced cardiac remodeling and supports the potential relevance of GPVI as therapeutic target to reduce ischemia reperfusion injury and to improve cardiac healing.
More Related Videos
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
09:29An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
Published on: July 14, 2023
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Intracellular Signaling Affects Focal Adhesions
Some...
Clot Retraction and Fibrinolysis
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...